Medical Science Liaison, Molecular Imaging; Cardiac Amyloidosis; West Coast

Select how often (in days) to receive an alert:

At Bayer, we believe work should matter. Every day, our teams push toward a future where  Health for all, Hunger for none  is within reach, and every role, from the lab to the field to the boardroom, helps us get there. We give people the ownership to shape outcomes, the support to grow through new skills and experiences, and a global community where different perspectives are valued.

If you want your work to count and the room to become your best, you'll find it here.

Bayer is seeking a field-based Medical Science Liaison (MSL) to serve as a credible scientific partner to healthcare professionals across a designated U.S. territory. The role is anchored in anchored in Molecular Imaging (Cardiac Amyloidosis) while supporting compliant scientific exchange across the multidisciplinary amyloidosis ecosystem, including cardiology, hematology/oncology, nuclear medicine, radiology, and integrated amyloidosis centers.

The MSL will build durable peer-to-peer relationships, generate actionable field insights, advance understanding of systemic and cardiac amyloidosis and its diagnostic pathway, support evidence-generation activities, and contribute to launch related field capability and institutional readiness. This is a field execution role focused on scientific engagement, insight generation, and cross-functional follow-through.

This position will focus on the West Coast (CA, OR, WA). Candidates should be domiciled within the Territory.

YOUR TASKS AND RESPONSIBILITIES

The primary responsibilities of this role, Medical Science Liaison, Molecular Imaging (Cardiac Amyloidosis)-West, are to:

• Identify, develop, and maintain compliant, high-value scientific relationships with cardiologists, heart-failure specialists, hematologists/oncologists, nuclear medicine physicians, radiologists, amyloidosis-center leaders, and other relevant stakeholders.
• Conduct balanced, peer-to-peer scientific exchange on systemic and cardiac amyloidosis, diagnostic pathways, clinical evidence, and investigational data in accordance with applicable policies and regulations.
• Deliver scientific presentations and disease-state education to appropriate healthcare professional and institutional audiences using approved resources.
• Execute a territory engagement plan that prioritizes relationship depth, multidisciplinary institutional reach, and meaningful follow-up.

• Gather, document, and communicate timely, high-quality insights on diagnostic and referral pathways, evidence gaps, educational needs, operational readiness, access themes, and barriers to adoption.
• Convert field observations into clearly framed insights that can inform Medical strategy, educational planning, evidence priorities, launch preparedness, and cross-functional action.
• Map the current diagnostic pathway and key decision points at priority institutions, including the roles of referring clinicians, imagers, readers, technologists, and multidisciplinary care teams.
• Use approved systems to document engagements, insights, follow-up, and territory-plan progress.

• Advance scientific understanding of systemic and cardiac amyloidosis, including unmet needs associated with under diagnosis, delayed diagnosis, and complex referral pathways.
• Identify institution-specific educational needs and support approved disease-state initiatives, advisory boards, congress activities, and other Medical Affairs programs.
• Engage stakeholders across cardiology, hematology/oncology, nuclear medicine, and radiology to develop a medically grounded view of how patients move through suspicion, referral, imaging, diagnosis, and follow-up.

• Support Bayer-sponsored research activities as appropriate, including investigator and site engagement, site identification, and scientific follow-up.
• Identify and appropriately triage investigator-initiated research concepts and evidence gaps through established Medical Affairs processes.
• Contribute to assigned evidence-generation, publication, congress, medical-resource, or advisory-board work streams, with clear documentation and follow-through.

• Develop a medically grounded view of priority-center readiness and identify gaps related to referral pathways, scientific understanding, readers, technologists, workflow, or infrastructure that require…